UGT1A1 and neoplasm: Although several meta-analyses have examined the correlation between UGT1A1 genotype and the efficacy of irinotecan-based regimens, including tumour response and survival (Palomaki et al, 2009; Dias et al, 2012; Liu et al, 2013; Dias et al, 2014), their results remain controversial.